Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000425004

Medchemexpress LLC Pegsebrenatide | 2243292-26-2 | 95.5% | 1 MG
SDP

Catalog No. 5000425004
Encompass_Preferred

Pegsebrenatide (NLY01) is a blood-brain barrier-penetrant GLP-1R agonist. It alleviates retinal inflammation and neuronal death, delays onset and reduces disease severity in experimental autoimmune encephalomyelitis, and exerts neuroprotective effects in Parkinson's disease models by preventing microglia-mediated conversion of astrocytes to the A1 neurotoxic phenotype. It is useful for research on glaucoma, Parkinson's disease, and multiple sclerosis.

  • Blood-brain barrier-penetrant GLP-1R agonist
  • Alleviates retinal inflammation and neuron death
  • Delays onset and reduces disease severity in experimental autoimmune encephalomyelitis
  • Inhibits formation of A1 reactive astrocytes
  • Reduces loss of retinal ganglion cells and dopaminergic neurons
  • Exerts neuroprotective effects in Parkinson's disease models
  • Useful for research on glaucoma, Parkinson's disease, and multiple sclerosis

Catalog No. 50-004-25004 Supplier Medchemexpress LLC Supplier No. HYP100191MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Pegsebrenatide (NLY01) is a blood-brain barrier-penetrant GLP-1R agonist. It alleviates retinal inflammation and neuronal death, delays onset and reduces disease severity in experimental autoimmune encephalomyelitis, and exerts neuroprotective effects in Parkinson's disease models by preventing microglia-mediated conversion of astrocytes to the A1 neurotoxic phenotype. It is useful for research on glaucoma, Parkinson's disease, and multiple sclerosis.

  • Blood-brain barrier-penetrant GLP-1R agonist
  • Alleviates retinal inflammation and neuron death
  • Delays onset and reduces disease severity in experimental autoimmune encephalomyelitis
  • Inhibits formation of A1 reactive astrocytes
  • Reduces loss of retinal ganglion cells and dopaminergic neurons
  • Exerts neuroprotective effects in Parkinson's disease models
  • Useful for research on glaucoma, Parkinson's disease, and multiple sclerosis

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.